Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
249
datasets available to search
ShareScore release 0.9.0
Dataset results
249 results for “infection tolerance”
A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
ClinicalTrials.gov study NCT00000743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)
ClinicalTrials.gov study NCT01081158. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents
ClinicalTrials.gov study NCT03332095. IPD Sharing: Not stated. Countries: 3. Publications: 0.
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU
ClinicalTrials.gov study NCT00000654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT05763576. IPD Sharing: NO. Countries: 7. Publications: 0.
Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
ClinicalTrials.gov study NCT00466180. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
ClinicalTrials.gov study NCT00146328. IPD Sharing: Not stated. Countries: 18. Publications: 0.
Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity
ClinicalTrials.gov study NCT05493969. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
ClinicalTrials.gov study NCT00614640. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
ClinicalTrials.gov study NCT04596319. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections
ClinicalTrials.gov study NCT05138822. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
ClinicalTrials.gov study NCT00002128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients
ClinicalTrials.gov study NCT01725529. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
ClinicalTrials.gov study NCT00775138. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
ClinicalTrials.gov study NCT00626795. IPD Sharing: NO. Countries: 2. Publications: 0.
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
ClinicalTrials.gov study NCT01110382. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)
ClinicalTrials.gov study NCT02174159. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061
ClinicalTrials.gov study NCT00348673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)
ClinicalTrials.gov study NCT00812331. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Data from: The genetic architecture of defence as resistance to and tolerance of bacterial infection in Drosophila melanogaster
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.